Medical Forum’s clinical editor Dr Joe Kosterich speaks with renowned nuclear physician Dr Joe Cardaci and dermatologist A/Prof Kurt Gebauer about Oncobeta’s innovative Rhenium-Skin Cancer Therapy, which is giving new hope for Australians with non-melanoma skin cancer.

Studies show that nearly 70% of Australians are expected to have at least one non-melanoma skin cancer excised in their lifetime.

Now patients with new or recurrent lesions where there are concerns for cosmetic or functional outcomes from surgery may be suitable for this innovative epidermal radioisotope therapy.

Rhenium-SCT is a single session, non-invasive treatment that is achieving complete response rates of >95% out to two years post-treatment.

------------

This podcast is exclusively for Australian medical practitioners. The content discussed is not appropriate for non-medical professionals. Please listen to our disclaimer provided at the end of the episode.

The information in this podcast is intended to be general information only and is no way intended to be medical advice, treatment or diagnoses. You acknowledge and agree that nothing in this product may be taken to be medical advice, treatment or a diagnosis by us or our podcast guests, nor are we or they intended to be a substitute for consulting a medical practitioner for your particular circumstances and needs. We do not accept any liability for injury, loss or damage incurred by the use of or reliance on the information provided in this podcast. This podcast may include the views or recommendations of third parties and does not necessarily reflect the views of Medical Forum - we assume no legal liability or responsibility for the accuracy, currency, or completeness of the information. If you require immediate medical attention, please contact 000 immediately or seek alternative and appropriate medical services.